• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Mutational analysis of the DOK2 haploinsufficient tumor suppressor gene in chronic myelomonocytic leukemia (CMML).

作者信息

Coppin E, Gelsi-Boyer V, Morelli X, Cervera N, Murati A, Pandolfi P P, Birnbaum D, Nunès J A

机构信息

1] Inserm U1068, Centre de Recherche en Cancérologie de Marseille, Marseille, France [2] Institut Paoli-Calmettes, Marseille, France [3] CNRS, UMR7258, Centre de Recherche en Cancérologie de Marseille, Marseille, France [4] Aix-Marseille University UM105, Marseille, France.

1] Cancer Genetics and Prevention Program, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA [2] Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA [3] Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

出版信息

Leukemia. 2015 Feb;29(2):500-2. doi: 10.1038/leu.2014.288. Epub 2014 Sep 25.

DOI:10.1038/leu.2014.288
PMID:25252871
Abstract
摘要

相似文献

1
Mutational analysis of the DOK2 haploinsufficient tumor suppressor gene in chronic myelomonocytic leukemia (CMML).
Leukemia. 2015 Feb;29(2):500-2. doi: 10.1038/leu.2014.288. Epub 2014 Sep 25.
2
Mutational analysis of DOK2 tumor suppressor gene in acute leukemias.急性白血病中DOK2肿瘤抑制基因的突变分析
Leuk Res. 2011 Jun;35(6):e87-8. doi: 10.1016/j.leukres.2011.01.027. Epub 2011 Feb 16.
3
Methylation-associated DOK1 and DOK2 down-regulation: Potential biomarkers for predicting adverse prognosis in acute myeloid leukemia.甲基化相关的 DOK1 和 DOK2 下调：预测急性髓系白血病不良预后的潜在生物标志物。
J Cell Physiol. 2018 Sep;233(9):6604-6614. doi: 10.1002/jcp.26271. Epub 2018 Mar 14.
4
All-trans retinoic acid induces p62DOK1 and p56DOK2 expression which enhances induced differentiation and G0 arrest of HL-60 leukemia cells.全反式维甲酸诱导p62DOK1和p56DOK2表达，这增强了HL-60白血病细胞的诱导分化和G0期阻滞。
Am J Hematol. 2006 Aug;81(8):603-15. doi: 10.1002/ajh.20667.
5
Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2, and DNMT3A.慢性粒单核细胞白血病的突变谱分析包括与表观遗传调控相关的基因：UTX、EZH2 和 DNMT3A。
Blood. 2011 Oct 6;118(14):3932-41. doi: 10.1182/blood-2010-10-311019. Epub 2011 Aug 9.
6
Transcriptomic rationale for synthetic lethality-targeting ERCC1 and CDKN1A in chronic myelomonocytic leukaemia.慢性粒单核细胞白血病中靶向 ERCC1 和 CDKN1A 的合成致死转录组学原理。
Br J Haematol. 2018 Aug;182(3):373-383. doi: 10.1111/bjh.15408. Epub 2018 May 24.
7
Overexpression of Arginase 1 is linked to DNMT3A and TET2 mutations in lower-grade myelodysplastic syndromes and chronic myelomonocytic leukemia.精氨酸酶1的过表达与低级别骨髓增生异常综合征和慢性粒单核细胞白血病中的DNMT3A和TET2突变有关。
Leuk Res. 2018 Feb;65:5-13. doi: 10.1016/j.leukres.2017.12.003. Epub 2017 Dec 6.
8
Clinical significance of CSF3R, SRSF2 and SETBP1 mutations in chronic neutrophilic leukemia and chronic myelomonocytic leukemia.CSF3R、SRSF2和SETBP1突变在慢性嗜中性粒细胞白血病和慢性粒单核细胞白血病中的临床意义
Oncotarget. 2017 Mar 28;8(13):20834-20841. doi: 10.18632/oncotarget.15355.
9
TET2 gene mutation is a frequent and adverse event in chronic myelomonocytic leukemia.TET2 基因突变是慢性粒单核细胞白血病中一种常见且具有不良预后的事件。
Haematologica. 2009 Dec;94(12):1676-81. doi: 10.3324/haematol.2009.011205. Epub 2009 Oct 1.
10
Mutational and expressional analysis of a haploinsufficient tumor suppressor gene DOK2 in gastric and colorectal cancers.
APMIS. 2011 Aug;119(8):562-4. doi: 10.1111/j.1600-0463.2011.02749.x. Epub 2011 Apr 25.

引用本文的文献

1
Chromosome-level Asian elephant genome assembly and comparative genomics of long-lived mammals reveal the common substitutions for cancer resistance.亚洲象染色体水平基因组组装及长寿命哺乳动物比较基因组揭示了癌症抗性的常见替代。
Aging Cell. 2023 Sep;22(9):e13917. doi: 10.1111/acel.13917. Epub 2023 Jul 3.
2
Introduction to DOK2 and its potential role in cancer.DOK2 简介及其在癌症中的潜在作用。
Physiol Res. 2021 Nov 29;70(5):671-685. doi: 10.33549/physiolres.934710. Epub 2021 Sep 10.
3
Genomic analysis of a riboflavin-overproducing Ashbya gossypii mutant isolated by disparity mutagenesis.

本文引用的文献

1
Mutational and expressional analysis of a haploinsufficient tumor suppressor gene DOK2 in gastric and colorectal cancers.
APMIS. 2011 Aug;119(8):562-4. doi: 10.1111/j.1600-0463.2011.02749.x. Epub 2011 Apr 25.
2
Mutational analysis of DOK2 tumor suppressor gene in acute leukemias.急性白血病中DOK2肿瘤抑制基因的突变分析
Leuk Res. 2011 Jun;35(6):e87-8. doi: 10.1016/j.leukres.2011.01.027. Epub 2011 Feb 16.
3
Downstream of tyrosine kinase 1 and 2 play opposing roles in CD200 receptor signaling.酪氨酸激酶 1 和 2 的下游在 CD200 受体信号中发挥相反的作用。
通过差异诱变分离的核黄素高产异常赤拟谷盗突变体的基因组分析。
BMC Genomics. 2020 Apr 23;21(1):319. doi: 10.1186/s12864-020-6709-7.
4
Exome-wide analysis identifies three low-frequency missense variants associated with pancreatic cancer risk in Chinese populations.外显子组全基因组分析鉴定出三个与中国人种胰腺癌风险相关的低频错义变异。
Nat Commun. 2018 Sep 11;9(1):3688. doi: 10.1038/s41467-018-06136-x.
5
Genomic and Epigenomic Signatures in Ovarian Cancer Associated with Resensitization to Platinum Drugs.卵巢癌中与铂类药物再敏感相关的基因组和表观基因组特征。
Cancer Res. 2018 Feb 1;78(3):631-644. doi: 10.1158/0008-5472.CAN-17-1492. Epub 2017 Dec 11.
6
Co-expression and significance of Dok2 and Ras p21 protein activator 1 in breast cancer.Dok2与Ras p21蛋白激活因子1在乳腺癌中的共表达及其意义
Oncol Lett. 2017 Nov;14(5):5386-5392. doi: 10.3892/ol.2017.6844. Epub 2017 Aug 28.
J Immunol. 2010 Dec 15;185(12):7216-22. doi: 10.4049/jimmunol.1002858. Epub 2010 Nov 15.
4
Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1.骨髓增殖性肿瘤中的新突变及其功能和临床相关性：JAK2、MPL、TET2、ASXL1、CBL、IDH 和 IKZF1。
Leukemia. 2010 Jun;24(6):1128-38. doi: 10.1038/leu.2010.69. Epub 2010 Apr 29.
5
Identification of DOK genes as lung tumor suppressors.鉴定 DOK 基因作为肺肿瘤抑制基因。
Nat Genet. 2010 Mar;42(3):216-23. doi: 10.1038/ng.527. Epub 2010 Feb 7.
6
The roles of Dok family adapters in immunoreceptor signaling.Dok 家族衔接蛋白在免疫受体信号中的作用。
Immunol Rev. 2009 Nov;232(1):273-85. doi: 10.1111/j.1600-065X.2009.00844.x.
7
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes.世界卫生组织（WHO）髓系肿瘤和急性白血病分类的2008年修订版：基本原理及重要变化
Blood. 2009 Jul 30;114(5):937-51. doi: 10.1182/blood-2009-03-209262. Epub 2009 Apr 8.
8
Cutting edge: Dok-1 and Dok-2 adaptor molecules are regulated by phosphatidylinositol 5-phosphate production in T cells.前沿：衔接分子Dok-1和Dok-2受T细胞中磷脂酰肌醇5-磷酸生成的调控。
J Immunol. 2009 Apr 1;182(7):3974-8. doi: 10.4049/jimmunol.0804172.
9
The myelodysplastic/myeloproliferative neoplasms: myeloproliferative diseases with dysplastic features.骨髓增生异常/骨髓增殖性肿瘤：具有发育异常特征的骨髓增殖性疾病。
Leukemia. 2008 Jul;22(7):1308-19. doi: 10.1038/leu.2008.119. Epub 2008 May 15.
10
Gene expression profiling separates chronic myelomonocytic leukemia in two molecular subtypes.
Leukemia. 2007 Nov;21(11):2359-62. doi: 10.1038/sj.leu.2404805. Epub 2007 Jun 14.